MOUNTAIN VIEW, Calif., May 17, 2012 (GLOBE NEWSWIRE) -- Singularity University today announced the companies selected to participate in its inaugural synthetic biology accelerator program, SynBio Startup Launchpad. The program will nurture aspiring SynBio entrepreneurs seeking to apply the rapid-cycle, low-cost approaches employed by tech and biotech startups. Synthetic biology is genetic engineering using software-based design tools coupled with low-cost DNA synthesis and assembly.

The SynBio Accerlator Program was conceived by Andrew Hessel, Co-Chair of SU's Biotechnology and Bioinformatics track, and John Cumbers, Ph.D, a synthetic biologist at NASA Ames Research Center. As Andrew Hessel explains, "advances in technology are allowing scientists to treat DNA, our genetic code, the same way people use code for software programming."

The SynBio Startup Launchpad is Singularity University's first formal initiative to support startups developing exponentially growing technologies. "The SynBio program brings together a powerful community seeking to support startups developing products from the emerging field of synthetic biology to address some of the world's biggest challenges," said Gabriel Baldinucci, Singularity University's Vice President of Strategy and New Venture Development.

Three (3) companies have been selected for the SynBio Program: Evolutionary Solutions, Modern Meadow and SoilGene. Evolutionary Solutions (founders Kettner Griswold and Paul Sebexen) is developing a genome synthesis device. Modern Meadow (co-founder Andras Forgacs) applies tissue-engineering techniques to produce high volumes of animal protein for food and textiles. SoilGene (founders Zachary Apte and Robert Lim) combines metagenomic and bioinformatic approaches to survey land opportunities for the natural resources and agriculture sectors.

A unique aspect of the SynBio program is its partnership with Triple Ring Technologies in Newark, California. The three selected companies will be based at Triple Ring to take advantage of its engineering and lab facilities, and their staff's extensive expertise in life sciences innovation and commercialization. "We are excited to work with the SynBio entrepreneurs taking innovations to market in the emerging synthetic biology space," said Joseph Heanue, Ph.D., president and CEO of Triple Ring Technologies.

The selected entrepreneurs will go through four months of comprehensive, customized mentoring and education in bringing their ideas to market. The companies receive close mentorship from a network of experienced advisors, weekly speakers on critical venture topics, networking with their peers, and valuable discounted services to launch their companies.

The first program will conclude in late August with the SynBio Companies pitching their ventures to investors and the community at "demo day" events.

Sandra Miller, newly appointed SU Managing Director of New Venture Development, will be responsible for the management of the SynBio Launchpad as well as other new Singularity University ventures, working closely with Gabriel Baldinucci, VP of Strategy and New Venture Development.

"Creating, incubating and financing companies to positively affect the lives of a billion people are central elements of SU's vision. We call this 10^9+ impact," said Dr. Peter H. Diamandis, SU Chairman and Co-Founder.

About Singularity University

Read this article:
Singularity University Announces Inaugural Synthetic Biology Accelerator Program